Advertisement
Screener

NeoGenomics, Inc. (NEO) Operating Cash Flow

2.8 / 5 stars · 68/120 Roast Me

NeoGenomics, Inc. Operating Cash Flow

NeoGenomics, Inc. (NEO) reported Operating Cash Flow of $11.82 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-07-28.

Financial Statements › Cash Flow › Operating Activities

us-gaap:NetCashProvidedByUsedInOperatingActivities · last filed 2026-07-28

  • NeoGenomics, Inc. net cash provided by (used in) operating activities for the quarter ending 2026-06-30 was $19.96M, a 1.82% decline year-over-year.
  • NeoGenomics, Inc. net cash provided by (used in) operating activities for the quarter ending 2026-03-31 was -$8.14M.
  • NeoGenomics, Inc. net cash provided by (used in) operating activities for the quarter ending 2025-12-31 was $1.34M, a 86.30% decline year-over-year.
  • NeoGenomics, Inc. net cash provided by (used in) operating activities for the quarter ending 2025-09-30 was $8.88M, a 3.92% decline year-over-year.
  • NeoGenomics, Inc. net cash provided by (used in) operating activities for fiscal 2025 was $5.23M, a 25.53% decline from fiscal 2024.
  • NeoGenomics, Inc. net cash provided by (used in) operating activities for fiscal 2024 was $7.02M.
  • NeoGenomics, Inc. net cash provided by (used in) operating activities for fiscal 2023 was -$1.95M.
  • NeoGenomics, Inc. net cash provided by (used in) operating activities for fiscal 2022 was -$65.99M.
Period endNet Cash Provided by (Used in) Operating Activities 3 monthNet Cash Provided by (Used in) Operating Activities 6 monthNet Cash Provided by (Used in) Operating Activities 9 monthNet Cash Provided by (Used in) Operating Activities 12 month
2026-06-30$19.96M
derived: 10-Q 6 month − 10-Q 3 month · filed 2026-07-28
$11.82M
10-Q · filed 2026-07-28
$13.16M
derived: sum of 3 quarters · filed 2026-07-28
$22.05M
derived: sum of 4 quarters · filed 2026-07-28
2026-03-31-$8.14M
10-Q · filed 2026-04-28
-$6.79M
derived: sum of 2 quarters · filed 2026-04-28
$2.09M
derived: sum of 3 quarters · filed 2026-04-28
$22.42M
derived: sum of 4 quarters · filed 2026-07-28
2025-12-31$1.34M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-17
$10.23M
derived: sum of 2 quarters · filed 2026-02-17
$30.56M
derived: sum of 3 quarters · filed 2026-07-28
$5.23M
10-K · filed 2026-02-17
2025-09-30$8.88M
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-28
$29.21M
derived: sum of 2 quarters · filed 2026-07-28
$3.89M
10-Q · filed 2025-10-28
$13.69M
derived: sum of 4 quarters · filed 2026-07-28
2025-06-30$20.33M
derived: 10-Q 6 month − 10-Q 3 month · filed 2026-07-28
-$5.00M
10-Q · filed 2026-07-28
$4.80M
derived: sum of 3 quarters · filed 2026-07-28
$14.05M
derived: sum of 4 quarters · filed 2026-07-28
2025-03-31-$25.33M
10-Q · filed 2026-04-28
-$15.53M
derived: sum of 2 quarters · filed 2026-04-28
-$6.28M
derived: sum of 3 quarters · filed 2026-04-28
$7.61M
derived: sum of 4 quarters · filed 2026-04-28
2024-12-31$9.80M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-17
$19.05M
derived: sum of 2 quarters · filed 2026-02-17
$32.94M
derived: sum of 3 quarters · filed 2026-02-17
$7.02M
10-K · filed 2026-02-17
2024-09-30$9.25M
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-28
$23.14M
derived: sum of 2 quarters · filed 2025-10-28
-$2.78M
10-Q · filed 2025-10-28
$15.01M
derived: sum of 4 quarters · filed 2026-02-17
2024-06-30$13.89M
derived: 10-Q 6 month − 10-Q 3 month · filed 2025-07-29
-$12.02M
10-Q · filed 2025-07-29
$5.76M
derived: sum of 3 quarters · filed 2026-02-17
$264.00K
derived: sum of 4 quarters · filed 2026-02-17
2024-03-31-$25.91M
10-Q · filed 2025-04-29
-$8.13M
derived: sum of 2 quarters · filed 2026-02-17
-$13.63M
derived: sum of 3 quarters · filed 2026-02-17
-$15.18M
derived: sum of 4 quarters · filed 2026-02-17
2023-12-31$17.78M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-17
$12.29M
derived: sum of 2 quarters · filed 2026-02-17
$10.74M
derived: sum of 3 quarters · filed 2026-02-17
-$1.95M
10-K · filed 2026-02-17
2023-09-30-$5.50M
derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-05
-$7.04M
derived: sum of 2 quarters · filed 2024-11-05
-$19.74M
10-Q · filed 2024-11-05
-$23.42M
derived: sum of 4 quarters · filed 2025-02-18
2023-06-30-$1.55M
derived: 10-Q 6 month − 10-Q 3 month · filed 2024-07-30
-$14.24M
10-Q · filed 2024-07-30
-$17.93M
derived: sum of 3 quarters · filed 2025-02-18
-$34.20M
derived: sum of 4 quarters · filed 2025-02-18
2023-03-31-$12.69M
10-Q · filed 2024-04-30
-$16.38M
derived: sum of 2 quarters · filed 2025-02-18
-$32.65M
derived: sum of 3 quarters · filed 2025-02-18
-$49.65M
derived: sum of 4 quarters · filed 2025-02-18
2022-12-31-$3.69M
derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-18
-$19.96M
derived: sum of 2 quarters · filed 2025-02-18
-$36.95M
derived: sum of 3 quarters · filed 2025-02-18
-$65.99M
10-K · filed 2025-02-18
2022-09-30-$16.27M
derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-06
-$33.27M
derived: sum of 2 quarters · filed 2023-11-06
-$62.31M
10-Q · filed 2023-11-06
-$82.08M
derived: sum of 4 quarters · filed 2024-02-20
2022-06-30-$17.00M
derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-08
-$46.04M
10-Q · filed 2023-08-08
-$65.81M
derived: sum of 3 quarters · filed 2024-02-20
-$73.58M
derived: sum of 4 quarters · filed 2024-02-20
2022-03-31-$29.04M
10-Q · filed 2023-05-09
-$48.82M
derived: sum of 2 quarters · filed 2024-02-20
-$56.58M
derived: sum of 3 quarters · filed 2024-02-20
-$57.97M
derived: sum of 4 quarters · filed 2024-02-20
2021-12-31-$19.78M
derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-20
-$27.54M
derived: sum of 2 quarters · filed 2024-02-20
-$28.93M
derived: sum of 3 quarters · filed 2024-02-20
-$26.72M
10-K · filed 2024-02-20
2021-09-30-$7.77M
derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-08
-$9.16M
derived: sum of 2 quarters · filed 2022-11-08
-$6.95M
10-Q · filed 2022-11-08
-$962.00K
derived: sum of 4 quarters · filed 2023-02-24
2021-06-30-$1.39M
derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-09
$820.00K
10-Q · filed 2022-08-09
$6.80M
derived: sum of 3 quarters · filed 2023-02-24
$7.33M
derived: sum of 4 quarters · filed 2023-02-24
2021-03-31$2.21M
10-Q · filed 2022-05-09
$8.20M
derived: sum of 2 quarters · filed 2023-02-24
$8.72M
derived: sum of 3 quarters · filed 2023-02-24
$10.60M
derived: sum of 4 quarters · filed 2023-02-24
2020-12-31$5.99M
derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-24
$6.51M
derived: sum of 2 quarters · filed 2023-02-24
$8.39M
derived: sum of 3 quarters · filed 2023-02-24
$1.46M
10-K · filed 2023-02-24
2020-09-30$526.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-04
$2.41M
derived: sum of 2 quarters · filed 2021-11-04
-$4.53M
10-Q · filed 2021-11-04
-$1.17M
derived: sum of 4 quarters · filed 2022-02-25
2020-06-30$1.88M
derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-09
-$5.05M
10-Q · filed 2021-08-09
-$1.69M
derived: sum of 3 quarters · filed 2022-02-25
$16.94M
derived: sum of 4 quarters · filed 2022-02-25
2020-03-31-$6.93M
10-Q · filed 2021-05-06
-$3.57M
derived: sum of 2 quarters · filed 2022-02-25
$15.06M
derived: sum of 3 quarters · filed 2022-02-25
$10.34M
derived: sum of 4 quarters · filed 2022-02-25
2019-12-31$3.36M
derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-25
$21.99M
derived: sum of 2 quarters · filed 2022-02-25
$17.27M
derived: sum of 3 quarters · filed 2022-02-25
$23.37M
10-K · filed 2022-02-25
2019-09-30$18.63M
derived: 10-Q 9 month − 10-Q 6 month · filed 2020-10-29
$13.91M
derived: sum of 2 quarters · filed 2020-10-29
$20.01M
10-Q · filed 2020-10-29
$35.46M
derived: sum of 4 quarters · filed 2021-02-25
2019-06-30-$4.72M
derived: 10-Q 6 month − 10-Q 3 month · filed 2020-07-31
$1.38M
10-Q · filed 2020-07-31
$16.83M
derived: sum of 3 quarters · filed 2021-02-25
$25.21M
derived: sum of 4 quarters · filed 2021-02-25
2019-03-31$6.10M
10-Q · filed 2020-04-29
$21.55M
derived: sum of 2 quarters · filed 2021-02-25
$29.93M
derived: sum of 3 quarters · filed 2021-02-25
$36.57M
derived: sum of 4 quarters · filed 2021-02-25
2018-12-31$15.45M
derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-25
$23.83M
derived: sum of 2 quarters · filed 2021-02-25
$30.47M
derived: sum of 3 quarters · filed 2021-02-25
$44.79M
10-K · filed 2021-02-25
2018-09-30$8.38M
derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-13
$15.02M
derived: sum of 2 quarters · filed 2019-11-13
$29.33M
10-Q · filed 2019-11-13
$35.09M
derived: sum of 4 quarters · filed 2020-02-28
2018-06-30$6.64M
derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-07
$20.95M
10-Q · filed 2019-08-07
$26.71M
derived: sum of 3 quarters · filed 2020-02-28
$34.15M
derived: sum of 4 quarters · filed 2020-02-28
2018-03-31$14.31M
10-Q · filed 2019-05-08
$20.07M
derived: sum of 2 quarters · filed 2020-02-28
$27.51M
derived: sum of 3 quarters · filed 2020-02-28
$34.03M
derived: sum of 4 quarters · filed 2020-02-28
2017-12-31$5.76M
derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-28
$13.20M
derived: sum of 2 quarters · filed 2020-02-28
$19.72M
derived: sum of 3 quarters · filed 2020-02-28
$18.04M
10-K · filed 2020-02-28
2017-09-30$7.44M
derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-06
$13.96M
derived: sum of 2 quarters · filed 2018-11-06
$12.28M
10-Q · filed 2018-11-06
2017-06-30$6.53M
derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-06
$4.84M
10-Q · filed 2018-08-06
2017-03-31-$1.69M
10-Q · filed 2018-05-08
2013-12-31-$505.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-24
$1.69M
derived: sum of 2 quarters · filed 2014-02-24
$3.56M
derived: sum of 3 quarters · filed 2014-02-24
$2.23M
10-K · filed 2014-02-24
2013-09-30$2.20M
derived: 10-Q 9 month − 10-Q 6 month · filed 2013-10-30
$4.06M
derived: sum of 2 quarters · filed 2013-10-30
$2.73M
10-Q · filed 2013-10-30
$2.73M
derived: sum of 4 quarters · filed 2014-02-24
2013-06-30$1.86M
derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-02
$533.00K
10-Q · filed 2013-08-02
$534.00K
derived: sum of 3 quarters · filed 2014-02-24
$25.00K
derived: sum of 4 quarters · filed 2014-02-24
2013-03-31-$1.33M
10-Q · filed 2013-05-13
-$1.33M
derived: sum of 2 quarters · filed 2014-02-24
-$1.84M
derived: sum of 3 quarters · filed 2014-02-24
-$757.00K
derived: sum of 4 quarters · filed 2014-02-24
2012-12-31$1.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-24
-$508.00K
derived: sum of 2 quarters · filed 2014-02-24
$573.00K
derived: sum of 3 quarters · filed 2014-02-24
-$492.00K
10-K · filed 2014-02-24
2012-09-30-$509.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2013-10-30
$572.00K
derived: sum of 2 quarters · filed 2013-10-30
-$493.00K
10-Q · filed 2013-10-30
$746.00K
derived: sum of 4 quarters · filed 2014-02-24
2012-06-30$1.08M
derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-02
$16.00K
10-Q · filed 2013-08-02
$1.25M
derived: sum of 3 quarters · filed 2014-02-24
$1.14M
derived: sum of 4 quarters · filed 2014-02-24
2012-03-31-$1.06M
10-Q · filed 2013-05-13
$174.00K
derived: sum of 2 quarters · filed 2014-02-24
$58.00K
derived: sum of 3 quarters · filed 2014-02-24
$548.00K
derived: sum of 4 quarters · filed 2014-02-24
2011-12-31$1.24M
derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-24
$1.12M
derived: sum of 2 quarters · filed 2014-02-24
$1.61M
derived: sum of 3 quarters · filed 2014-02-24
$69.00K
10-K · filed 2014-02-24
2011-09-30-$116.00K
derived: 10-Q 9 month − 10-Q/A 6 month · filed 2012-11-05
$374.00K
derived: sum of 2 quarters · filed 2012-11-05
-$1.17M
10-Q · filed 2012-11-05
-$809.00K
derived: sum of 4 quarters · filed 2012-11-05
2011-06-30$490.00K
derived: 10-Q/A 6 month − 10-Q 3 month · filed 2012-08-15
-$1.05M
10-Q/A · filed 2012-08-15
-$693.00K
derived: sum of 3 quarters · filed 2012-08-15
-$1.62M
derived: sum of 4 quarters · filed 2012-08-15
2011-03-31-$1.54M
10-Q · filed 2012-05-14
-$1.18M
derived: sum of 2 quarters · filed 2012-05-14
-$2.11M
derived: sum of 3 quarters · filed 2012-05-14
2010-12-31$361.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2012-03-12
-$564.00K
derived: sum of 2 quarters · filed 2012-03-12
-$2.05M
10-K · filed 2012-03-12
2010-09-30-$925.00K
derived: 10-Q 9 month − 10-Q/A 6 month · filed 2011-10-25
-$2.41M
10-Q · filed 2011-10-25
2010-06-30-$1.49M
10-Q/A · filed 2011-08-01

Similar stocks

Stock NameCountryMarket CapPE Ratio
20/20 Biolabs, Inc. (AIDX)United States$0.005B